A Randomized, Double-Blind, Placebo and Positive Controlled, Parallel Group Trial to Investigate the Effect of Multiple Doses of NOMAC-E2 on QT/QTc Interval in Healthy Women

Trial Profile

A Randomized, Double-Blind, Placebo and Positive Controlled, Parallel Group Trial to Investigate the Effect of Multiple Doses of NOMAC-E2 on QT/QTc Interval in Healthy Women

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Nov 2014

At a glance

  • Drugs Estradiol/nomegestrol (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 29 Apr 2014 Results published in the Clinical Drug Investigation.
    • 12 Oct 2012 Results presented at the 20th FIGO World Congress of Gynecology and Obstetrics.
    • 28 Oct 2009 Schering-Plough added as trial sponsor as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top